© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

Covid: AstraZeneca vaccine 79% effective with no increased blood clot risk – US trial

Study of over 32,000 people included review of risks of cerebral venous sinus thrombosis

  • Coronavirus – latest updates
  • See all our coronavirus coverage

The Covid-19 vaccine developed by Oxford University and AstraZeneca was 79% effective in preventing symptomatic illness in a large trial in the US, Chile and Peru, the company said on Monday, paving the way for it to apply for US approval.

The vaccine was 100% effective against severe or critical disease and hospitalisation and was safe, the drugmaker said on Monday, releasing results of the late-stage human trial study of more than 32,000 volunteers across all age groups.

Continue reading…

Related posts

Keir Starmer blasts ‘Whitehall knows best’ Covid attitude

AEA3

PM to lead Commons tributes to David Amess as family call for unity

AEA3

Rangers crowned Scottish champions to end Celtic’s nine-year reign

AEA3

Pin It on Pinterest

Share This